文献速递哮喘

乌干达哮喘急性加重率与死亡率及相关因素:两年队列研究

Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study.
PubMed 文献 · Thorax · 2018-05-11

该研究前瞻性随访乌干达449例哮喘患者(5-93岁)2年,发现中位急性加重次数1次(IQR 0-5),死亡17例(3.7%,27.3/1000人年)。首年59.6%患者至少一次急性加重,32.4%三次及以上。良好哮喘控制(ACT评分高)与较低加重风险相关,基线前一年加重次数多则风险高;FEV1越高全因死亡风险越低。

要点

  • 乌干达哮喘患者急性加重与死亡率高,与哮喘控制不佳相关
  • 首年59.6%至少一次加重,32.4%三次及以上加重
  • 较高FEV1与较低全因死亡风险独立相关

核心结论

  • 乌干达哮喘患者急性加重率和死亡率高,且与哮喘控制不佳相关,应加强卫生系统对哮喘患者的管理。

研究设计与样本

  • 前瞻性队列研究,纳入449例哮喘患者(年龄5-93岁),在乌干达随访2年,确定急性加重率、死亡率及相关因素。

主要发现

  • 随访期间每患者中位急性加重次数为1次(IQR 0-5),17例死亡(3.7%,27.3/1000人年)。
  • 仅首年随访中,59.6%患者至少经历一次急性加重,32.4%经历三次及以上急性加重。
  • 多变量模型显示,首年至少一次急性加重的可能性随基线哮喘控制更好(ACT评分更高)而降低(OR 0.87,95%CI 0.82-0.93,P=0.000),随入组前一年加重次数更多而升高(对数加重次数OR 1.28,95%CI 1.04-1.57,P=0.018)。
  • 首年三次及以上急性加重的独立相关因素仅为更好哮喘控制(OR 0.93,95%CI 0.88-0.99,P=0.021)和基线加重次数(OR 1.35,95%CI 1.11-1.66,P=0.005)。
  • 与全因死亡率相关的唯一因素是FEV1,近期FEV1越高全因死亡率越低(OR 0.30,95%CI 0.14-0.65,P=0.002)。

临床怎么用

  • 对哮喘患者应评估基线ACT评分和既往一年急性加重次数以识别高加重风险者。
  • 监测FEV1有助于评估全因死亡风险。
  • 在资源有限地区需加强卫生系统对哮喘的长期管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Data on asthma treatment outcomes in Africa are limited. 449 patients with asthma (age 5-93 years) in Uganda were followed up for 2 years to determine rates of exacerbations and mortality and associated factors. During follow-up the median number of exacerbations per patient was 1 (IQR 0-5) and 17 patients died (3.7%, 27.3 deaths per 1000 person years). Considering only the first year of follow-up, 59.6% of the patients experienced at least one exacerbation, 32.4% experienced three or more exacerbations. A multivariable model showed that the likelihood of experiencing at least one exacerbation in the first year of follow-up was lower with better baseline asthma control (higher asthma control test (ACT) score), with OR 0.87 (95% CI: 0.82 to 0.93, P=0.000), and was higher with more exacerbations in the year prior to enrolment (OR for log number of exacerbations 1.28, 95% CI: 1.04 to 1.57, P=0.018). Better asthma control (OR 0.93, 95% CI: 0.88 to 0.99, P=0.021) and number of baseline exacerbations (OR 1.35,95% CI: 1.11 to 1.66, P=0.005) were also the only factors that were independently associated with experiencing three or more exacerbations during the first year of follow-up. The only factor found to be associated with all-cause mortality was FEV1, with higher recent FEV1 associated with lower all-cause mortality (OR 0.30, 95% CI: 0.14 to 0.65; P=0.002). Rates of asthma exacerbations and mortality are high in Uganda and are associated with poor asthma control. Health systems should be strengthened to care for asthma patients.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Kirenga BJ, de Jong C, Mugenyi L, et al. Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study. Thorax. 2018. PMID: 29752346. doi:10.1136/thoraxjnl-2017-211157

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。